Resistance of neonatal primary astrocytes against Fas-induced apoptosis depends on silencing of caspase 8

Neuroscience Letters

Volumn 479, Issue 3, 2010, Pages 206-210

  Barca, Olga ^a   Carneiro, Carmen ^a   Costoya, José A ^a   Señarís, Rosa M ^a   Arce, Víctor M ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Apoptosis; Astrocyte; Caspase 8; Epigenetic; Fas; FasL

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CASPASE 8; FAS ANTIGEN; GENOMIC DNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DNA METHYLATION; DNA MODIFICATION; FETUS; FLUORESCENCE MICROSCOPY; GENE SILENCING; GENETIC TRANSFECTION; NEWBORN; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION; ANIMAL; BIOSYNTHESIS; BRAIN CORTEX; CYTOLOGY; GENETICS; SPRAGUE DAWLEY RAT;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; ASTROCYTES; CASPASE 8; CEREBRAL CORTEX; GENE SILENCING; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION;

EID: 77954143557     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.05.057     Document Type: Article

References (30)

1. Barca O., Costoya J.A., Señarís R.M., Arce V.M. Interferon-beta protects astrocytes against tumour necrosis factor-induced apoptosis via activation of p38 mitogen-activated protein kinase. Exp. Cell Res. 2008, 314:2231-2237.
2. Barca O., Ferré S., Seoane M., Prieto J.M., Lema M., Señarís R., Arce V.M. Interferon beta promotes survival in primary astrocytes through phosphatidylinositol 3-kinase. J. Neuroimmunol. 2003, 139:155-159.
3. Becher B., D'Souza S.D., Troutt A.B., Antel J.P. Fas expression on human fetal astrocytes without susceptibility to fas-mediated cytotoxicity. Neuroscience 1998, 84:627-634.
4. Bechmann I., Lossau S., Steiner B., Mor G., Gimsa U., Nitsch R. Reactive astrocytes upregulate Fas (CD95) and Fas ligand (CD95L) expression but do not undergo programmed cell death during the course of anterograde degeneration. Glia 2000, 32:25-41.
5. Beer R., Franz G., Schöpf M., Reindl M., Zelger B., Schmutzhard E., Poewe W., Kampfl A. Expression of Fas and Fas ligand after experimental traumatic brain injury in the rat. J. Cereb. Blood Flow. Metab. 2000, 20:669-677.
6. Boldin M.P., Goncharov T.M., Goltsev Y.V., Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 1996, 85:803-815.
7. Choi C., Benveniste E.N. Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses. Brain Res. Brain Res. Rev. 2004, 44:65-81.
8. Choi C., Park J.Y., Lee J., Lim J.H., Shin E.C., Ahn Y.S., Kim C.H., Kim S.J., Kim J.D., Choi I.S., Choi I.H. Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma. J. Immunol. 1999, 162:1889-1895.
9. Curtin J.F., Cotter T.G. Live and let die: regulatory mechanisms in Fas-mediated apoptosis. Cell Signal. 2003, 15:983-992.
10. Falsig J., Latta M., Leist M. Defined inflammatory states in astrocyte cultures: correlation with susceptibility towards CD95-driven apoptosis. J. Neurochem. 2004, 88:181-193.
11. Harada K., Toyooka S., Shivapurkar N., Maitra A., Reddy J.L., Matta H., Miyajima K., Timmons C.F., Tomlinson G.E., Mastrangelo D., Hay R.J., Chaudhary P.M., Gazdar A.F. Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines. Cancer Res. 2002, 62:5897-5901.
12. Hopkins-Donaldson S., Bodmer J.L., Bourloud K.B., Brognara C.B., Tschopp J., Gross N. Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Cancer Res. 2000, 60:4315-4319.
13. Li L.C., Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002, 18:1427-1431.
14. Martinez R., Setien F., Voelter C., Casado S., Quesada M.P., Schackert G., Esteller M. CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme. Carcinogenesis 2007, 28:1264-1268.
15. Matsuyama T., Hata R., Tagaya M., Yamamoto Y., Nakajima T., Furuyama J., Wanaka A., Sugita M. Fas antigen mRNA induction in postischemic murine brain. Brain Res. 1994, 657:342-346.
16. Muzio M., Salvesen G.S., Dixit V.M. FLICE induced apoptosis in a cell-free system. Cleavage of caspase zymogens. J. Biol. Chem. 1997, 272:2952-2956.
17. Park C., Sakamaki K., Tachibana O., Yamashima T., Yamashita J., Yonehara S. Expression of Fas antigen in the normal mouse brain. Biochem. Biophys. Res. Commun. 1998, 252:623-628.
18. Pingoud-Meier C., Lang D., Janss A.J., Rorke L.B., Phillips P.C., Shalaby T., Grotzer M.A. Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma. Clin. Cancer Res. 2003, 9:6401-6409.
19. Rice P., Longden I., Bleasby A. EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet. 2000, 16:276-277.
20. Saas P., Boucraut J., Quiquerez A.L.V., Schnuriger, Perrin G., Desplat-Jego S., Bernard D., Walker P.R., Dietrich P.Y. CD95 (Fas/Apo-1) as a receptor governing astrocyte apoptotic or inflammatory responses: a key role in brain inflammation?. J. Immunol. 1999, 162:2326-2333.
21. Sakamaki K, Tsukumo S., Yonehara S. Molecular cloning and characterization of mouse caspase-8. Eur. J. Biochem. 1998, 253:399-405.
22. Sato T., Irie S., Kitada S., Reed J.C. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 1995, 268:411-415.
23. Shin S.W., Park J.W., Suh M.H., Suh S.I., Choe B.K. Persistent expression of Fas/FasL mRNA in the mouse hippocampus after a single NMDA injection. J. Neurochem. 1998, 71:1773-1776.
24. Soengas M.S., Capodieci P., Polsky D., Mora J., Esteller M., Opitz-Araya X., McCombie R., Herman J.G., Gerald W., Lazebnik Y.A., Cordon-Cardo C., Lowe S.W. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 2001, 409:207-211.
25. Song J.H., Bellail A., Tse M.C., Yong V.W., Hao C. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. J. Neurosci. 2006, 26:3299-3308.
26. Tan Z., Levid J., Schreiber S.S. Increased expression of Fas (CD95/APO-1) in adult rat brain after kainate-induced seizures. Neuroreport 2001, 12:1979-1982.
27. Wajant H. The Fas signaling pathway: more than a paradigm. Science 2002, 296:1635-1636.
28. Wosik K., Becher B., Ezman A., Nalbantoglu J., Antel J.P. Caspase 8 expression and signaling in Fas injury-resistant human fetal astrocytes. Glia 2001, 33:217-224.
29. Yanagisawa J., Takahashi M., Kanki H., Yano-Yanagisawa H., Tazunoki T., Sawa E., Nishitoba T., Kamishohara M., Kobayashi E., Kataoka S., Sato T. The molecular interaction of Fas and FAP-1. A tripeptide blocker of human Fas interaction with FAP-1 promotes Fas-induced apoptosis. J. Biol. Chem. 1997, 272:8539-8545.
30. Yun K., Jinno Y., Sohda T., Niikawa N., Ikeda T. Promoter-specific insulin-like growth factor 2 gene imprinting in human fetal liver and hepatoblastoma. J. Pathol. 1998, 185:91-98.